Using Early Time-Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults with Type 2 Diabetes
Abstract
In this clinical trial, we will test whether two circadian-based therapies--a form of meal timing called early time-restricted eating (eTRE) and timed light therapy--can improve blood sugar control in adults with type 2 diabetes. Approximately 344 adults with type 2 diabetes will be randomized to the following 2 x 2 study design: (1) control group, (2) eTRF, (3)timed light therapy, and (4) eTRF and timed light therapy. Participants will follow their assigned lifestyle intervention for 16 weeks and be followed for a total of one year. In addition, we will determine whether the two circadian therapies can improve circadian rhythms, sleep quality, weight loss, cardiovascular health, quality of life, and psychological health. We are currently enrolling participants and collecting data. The delivery of the intervention is going well, and adherence is high. We experimented with several different approaches to recruitment and advertising. In the past three months, we experienced a major improvement in recruitment, and we are now confident that we can recruit participants at our target rate.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2022
- Accession Number
- AD1190777
Entities
People
- Courtney M. Peterson
- Lynn Dill
Organizations
- University of Alabama